ArticleNanomaterials (Basel, Switzerland)2025
Nanostructured Sr-Doped Hydroxyapatite: A Material with Antimicrobial Potential.
Article in Nanomaterials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Multifunctional Xanthan Gum-Hydroxyapatite Composite with Enhanced Dye Adsorption, Antibacterial Activity, and Cytocompatibility.Materials (Basel, Switzerland) · 2026Article
- Metal-Substituted Hydroxyapatite Nanoparticles as Antimicrobial and Osteogenic Biomaterials for Hard-Tissue Applications.Materials (Basel, Switzerland) · 2026Review
- Effect of Strontium Peroxide and Copper-Doped Hydroxyapatite Microceramics on the Osteogenesis and Antibacterial Activity of Nanofibrous Composite Scaffolds.Materials (Basel, Switzerland) · 2026Article
- Structure-Driven Bioactivity of Chitosan-Agarose-Gelatin Hydrogels Functionalized with Tannic Acid-CuACS applied materials & interfaces · 2026Article
- Calcium Phosphate Nanostructured Biocomposites with Applications in Bone Tissue Engineering.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
This research investigated the feasibility of producing strontium-doped nanocrystalline hydroxyapatite (SrHAp) through an environmentally benign synthesis approach and evaluated the antimicrobial activity of the resulting material. The synthesized nanomaterial was subjected to comprehensive characterization. The antimicrobial efficacy of SrHAp was tested against Gram-positive and Gram-negative bacterial strains. X-ray diffraction (XRD) analysis in combination with Fourier-transform infrared (FT-IR) spectroscopy confirmed the successful formation of pure monocrystalline SrHAp. The scanning electron microscopy (SEM) examination revealed two predominant morphological structures: nanorods and prismatic configurations of the SrHAp. Transmission electron microscopy (TEM) demonstrated that the rod-like SrHAp nanocrystals aggregate into elongated grain structures with a size of about 25 nm × 10 nm. Inductively coupled plasma-optical emission spectroscopy (ICP-OES) analysis confirmed the presence and quantification of the concentrations of calcium, strontium, and phosphorus, while confirming the expected calcium-phosphorus ratio characteristic of hydroxyapatite. The study established that the positive surface charge of the material, with a point of zero charge near pH 10, is essential for its antimicrobial efficiency. These results suggest that SrHAp nanomaterials hold promise for biomedical applications, particularly as antimicrobial coatings for implants and scaffolds for bone tissue, where the prevention of infection is critical. Overall, despite its selective and material quantity-dependent antimicrobial efficacy, environmentally friendly synthesized SrHAp can be successfully applied as an effective controller of targeted microbial contamination, especially of Gram-positive bacterial species
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.